Literature DB >> 30062433

Rectal perforation after Doppler-guided hemorrhoidal dearterialization treated with diverting sigmoidostomy.

A Sturiale1, D Cafaro2, B Fabiani2, U Ferro3, G Naldini2.   

Abstract

Entities:  

Mesh:

Year:  2018        PMID: 30062433     DOI: 10.1007/s10151-018-1824-z

Source DB:  PubMed          Journal:  Tech Coloproctol        ISSN: 1123-6337            Impact factor:   3.781


× No keyword cloud information.
  2 in total

1.  A prospective randomized trial on transanal hemorrhoidal dearterialization versus stapler hemorrhoidectomy: methodological issues that need to be clarified.

Authors:  S Biondo; L Trenti; E Kreisler; C Ratto
Journal:  Tech Coloproctol       Date:  2017-10-28       Impact factor: 3.781

2.  THD Doppler procedure for hemorrhoids: the surgical technique.

Authors:  C Ratto
Journal:  Tech Coloproctol       Date:  2013-09-12       Impact factor: 3.781

  2 in total
  4 in total

1.  Comments on a systematic review assessing the outcomes of stapled hemorrhoidopexy versus open hemorrhoidectomy.

Authors:  G Naldini; A Sturiale
Journal:  Tech Coloproctol       Date:  2021-02-15       Impact factor: 3.781

2.  Intra-abdominal rectal perforation post-haemorrhoidal artery ligation operation and converted Ligasure open haemorrhoidectomy.

Authors:  Natalie Simon; Noshin Saiyara; Hyun-Kyung Kim; Yuksel Gercek
Journal:  J Surg Case Rep       Date:  2021-07-09

3.  Improvement in Hemorrhoidal Disease Surgery Outcomes Using a New Anatomical/Clinical-Therapeutic Classification (A/CTC).

Authors:  Gabriele Naldini; Filippo Caminati; Alessandro Sturiale; Bernardina Fabiani; Danilo Cafaro; Claudia Menconi; Domenico Mascagni; Felipe Celedon Porzio
Journal:  Surg J (N Y)       Date:  2020-09-10

Review 4.  A systematic review of the literature assessing the outcomes of stapled haemorrhoidopexy versus open haemorrhoidectomy.

Authors:  Q Z Ruan; W English; A Hotouras; C Bryant; F Taylor; S Andreani; S D Wexner; S Banerjee
Journal:  Tech Coloproctol       Date:  2020-10-24       Impact factor: 3.781

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.